Warren Buffett’s Best High-Yield Dividend Stocks
At the end of 2015, Warren Buffett owned a total of 44 publicly-traded stocks.
Sanofi Aventis (SNY)
Market is closed
News
- First
- << Previous
- 121 - 130
- Next >>
Here is What Hedge Funds Think About Sanofi SA (ADR) (SNY)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Billionaire Ken Fisher's Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast as it began”, and he...
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both stocks did not move significantly...
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus
In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to tackle chronic diseases ...
Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock
On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report at the U.S.
Abrams Capital Management Trims the Stake in Engility Holdings Inc (EGL)
Abrams Capital Management, led by David Abrams significantly trimmed its stake in Engility Holdings Inc (NYSE:EGL).
Everything You Need to Know About the Upcoming Flu Season
To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.
Four Reasons to Buy This Biotechnology Stock
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best performing stocks in the biotechnology sector this...
- First
- << Previous
- 121 - 130
- Next >>
Billionaire Hedge Funds
